Correlations in Nuclear Arrhenius-Type Plots

Arrhenius-type plots for multifragmentation process, defined as the transverse energy dependence of the single-fragment emission-probability, -ln(p_{b}) vs 1/sqrt(E_{t}), have been studied by examining the relationship of the parameters p_{b} and E_{t} to the intermediate-mass fragment multiplicity . The linearity of these plots reflects the correlation of the fragment multiplicity with the transverse energy. These plots may not provide thermal scaling information about fragment production as previously suggested.Comment: 12 pages, Latex, 3 Postscript figures include

A statistical interpretation of the correlation between intermediate mass fragment multiplicity and transverse energy

Multifragment emission following Xe+Au collisions at 30, 40, 50 and 60 AMeV has been studied with multidetector systems covering nearly 4-pi in solid angle. The correlations of both the intermediate mass fragment and light charged particle multiplicities with the transverse energy are explored. A comparison is made with results from a similar system, Xe+Bi at 28 AMeV. The experimental trends are compared to statistical model predictions.Comment: 7 pages, submitted to Phys. Rev.

Z-dependent Barriers in Multifragmentation from Poissonian Reducibility and Thermal Scaling

We explore the natural limit of binomial reducibility in nuclear multifragmentation by constructing excitation functions for intermediate mass fragments (IMF) of a given element Z. The resulting multiplicity distributions for each window of transverse energy are Poissonian. Thermal scaling is observed in the linear Arrhenius plots made from the average multiplicity of each element. ``Emission barriers'' are extracted from the slopes of the Arrhenius plots and their possible origin is discussed.Comment: 15 pages including 4 .ps figures. Submitted to Phys. Rev. Letters. Also available at http://csa5.lbl.gov/moretto

Charge correlations and dynamical instabilities in the multifragment emission process

A new, sensitive method allows one to search for the enhancement of events with nearly equal-sized fragments as predicted by theoretical calculations based on volume or surface instabilities. Simulations have been performed to investigate the sensitivity of the procedure. Experimentally, charge correlations of intermediate mass fragments emitted from heavy ion reactions at intermediate energies have been studied. No evidence for a preferred breakup into equal-sized fragments has been found.Comment: 12 pages, TeX type, psfig, submitted to Phys. Rev. Lett, also available at http://csa5.lbl.gov/moretto/ps/zcor_pp.p

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT

Background: Neutropenic sepsis is a common complication of systemic anticancer treatment. There is variation in practice in timing of switch to oral antibiotics after commencement of empirical intravenous antibiotic therapy. Objectives: To establish the clinical and cost effectiveness of early switch to oral antibiotics in patients with neutropenic sepsis at low risk of infective complications. Design: A randomised, multicentre, open-label, allocation concealed, non-inferiority trial to establish the clinical and cost effectiveness of early oral switch in comparison to standard care. Setting: Nineteen UK oncology centres. Participants: Patients aged 16 years and over receiving systemic anticancer therapy with fever (≥ 38\ub0C), or symptoms and signs of sepsis, and neutropenia (≤ 1.0 7 109/l) within 24 hours of randomisation, with a Multinational Association for Supportive Care in Cancer score of ≥ 21 and receiving intravenous piperacillin/tazobactam or meropenem for < 24 hours were eligible. Patients with acute leukaemia or stem cell transplant were excluded. Intervention: Early switch to oral ciprofloxacin (750 mg twice daily) and co-amoxiclav (625 mg three times daily) within 12-24 hours of starting intravenous antibiotics to complete 5 days treatment in total. Control was standard care, that is, continuation of intravenous antibiotics for at least 48 hours with ongoing treatment at physician discretion. Main outcome measures: Treatment failure, a composite measure assessed at day 14 based on the following criteria: fever persistence or recurrence within 72 hours of starting intravenous antibiotics; escalation from protocolised antibiotics; critical care support or death. Results: The study was closed early due to under-recruitment with 129 patients recruited; hence, a definitive conclusion regarding non-inferiority cannot be made. Sixty-five patients were randomised to the early switch arm and 64 to the standard care arm with subsequent intention-to-treat and per-protocol analyses including 125 (intervention n = 61 and control n = 64) and 113 (intervention n = 53 and control n = 60) patients, respectively. In the intention-to-treat population the treatment failure rates were 14.1% in the control group and 24.6% in the intervention group, difference = 10.5% (95% confidence interval 0.11 to 0.22). In the per-protocol population the treatment failure rates were 13.3% and 17.7% in control and intervention groups, respectively; difference = 3.7% (95% confidence interval 0.04 to 0.148). Treatment failure predominantly consisted of persistence or recurrence of fever and/or physician-directed escalation from protocolised antibiotics with no critical care admissions or deaths. The median length of stay was shorter in the intervention group and adverse events reported were similar in both groups. Patients, particularly those with care-giving responsibilities, expressed a preference for early switch. However, differences in health-related quality of life and health resource use were small and not statistically significant. Conclusions: Non-inferiority for early oral switch could not be proven due to trial under-recruitment. The findings suggest this may be an acceptable treatment strategy for some patients who can adhere to such a treatment regimen and would prefer a potentially reduced duration of hospitalisation while accepting increased risk of treatment failure resulting in re-admission. Further research should explore tools for patient stratification for low-risk de-escalation or ambulatory pathways including use of biomarkers and/or point-of-care rapid microbiological testing as an adjunct to clinical decision-making tools. This could include application to shorter-duration antimicrobial therapy in line with other antimicrobial stewardship studies. Trial registration: This trial is registered as ISRCTN84288963. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/140/05) and is published in full in Health Technology Assessment; Vol. 28, No. 14. See the NIHR Funding and Awards website for further award information.Neutropenic sepsis, or infection with a low white blood cell count, can occur following cancer treatment. Usually patients receive treatment with intravenous antibiotics (antibiotics delivered into a vein) for two or more days. Patients at low risk of complications from their infection may be able to have a shorter period of intravenous antibiotics benefitting both patients and the NHS. The trial compared whether changing from intravenous to oral antibiotics (antibiotics taken by mouth as tablets or liquid) 12–24 hours after starting antibiotic treatment (‘early switch’) is as effective as usual care. Patients could take part if they had started intravenous antibiotics for low-risk neutropenic sepsis. Patients were randomly allocated to ‘early switch’ or to usual care. The main outcome measured was treatment failure. Treatment failure happened if fever persisted or recurred despite antibiotics, if patients needed to change antibiotics, if they needed to be re-admitted to hospital or needed to be admitted to intensive care within 14 days or died. We had originally intended that 628 patients would take part, but after review of the design of the study the number needed to take part was revised to 230. We were not able to complete the trial as planned as unfortunately only 129 patients took part. As the trial was smaller than expected we were not able to draw conclusions as to whether ‘early switch’ is no less effective than usual care. Our findings suggest that ‘early switch’ might result in a shorter time in hospital initially; however, treatment failure was more likely to occur, meaning some patients had to return to hospital for further antibiotics. There were no differences in side effects and no serious complications from treatment or treatment failure (such as intensive care admission or death) among the 65 patients in the ‘early switch’ group. Patients were satisfied with ‘early switch’. Early switch may be a treatment option for some patients with low-risk neutropenic sepsis who would prefer a shorter duration of hospital admission but accept a risk of needing hospital re-admission

Circumstantial Evidence for a Critical Behavior in Peripheral Au + Au Collisions at 35 MeV/nucleon

The fragmentation resulting from peripheral Au + Au collisions at an incident energy of E = 35 MeV/nucleon is investigated. A power-law charge distribution, $A^{-\tau}$ with $\tau \approx 2.2$, and an intermittency signal are observed for events selected in the region of the Campi scatter plot where "critical" behavior is expected.Comment: 11 pages, RevTex file, 4 postscript figures available upon request from [email protected]

To the Continuum and Beyond: Structure of U Nuclei

An experiment was performed at the 88-inch cyclotron at LBNL to investigate the structure of uranium isotopes and concurrently test the so-called surrogate ratio method. A 28 MeV proton beam was used to bombard 236U and 238U targets and the outgoing light ions were detected using the STARS silicon telescope allowing isotopic assignments and the excitation energy of the compound nucleus to be measured. A fission detector was placed at backward angles to give particle-fission coincidences, while the six clover germanium detectors of the LIBERACE array were used for particle-γ coincidences. The (p,d) reaction channels on 236U and 238U targets were used as a surrogate to measure the σ(234U(n,f))/σ(236U(n,f)) cross section ratio. The results give reasonable agreement with literature values over an equivalent neutron energy range between 0 MeV and 6 MeV. Structure results in 235U include a new (3/2−) level at 1035 keV, that is tentatively assigned as the 3/2−[501] Nilsson state. The analogue 3/2−[501] state in 237U may be associated with a previously observed level at 1201 keV, whose spin/parity is restricted to Jπ = 3/2− on the basis of newly observed decays to the ground band

Searching for the Nuclear Liquid-Gas Phase Transition in Au + Au Collisions at 35 MeV/nucleon

Within the framework of Classical Molecular Dynamics, we study the collision Au + Au at an incident energy of 35 MeV/nucleon. It is found that the system shows a critical behaviour at peripheral impact parameters, revealed through the analysis of conditional moments of charge distributions, Campi Scatter Plot, and the occurrence of large fluctuations in the region of the Campi plot where this critical behaviour is expected. When applying the experimental filters of the MULTICS-MINIBALL apparatus, it is found that criticality signals can be hidden due to the inefficiency of the experimental apparatus. The signals are then recovered by identifying semi-peripheral and peripheral collisions looking to the velocity distribution of the largest fragment, then by selecting the most complete events.Comment: RevTex file, 21 pages + 19 figures available upon request from [email protected]

Utilizing (\u3cem\u3ep,d\u3c/em\u3e) and (\u3cem\u3ep,t\u3c/em\u3e) Reactions to Obtain (\u3cem\u3en,f\u3c/em\u3e) Cross Sections in Uranium Nuclei Via the Surrogate-Ratio Method

The surrogate ratio method has been tested for (p,d) and (p,t) reactions on uranium nuclei. 236U and 238U targets were bombarded with 28-MeV protons and the light ion recoils and fission fragments were detected using the Silicon Telescope Array for Reaction Studies detector array at the 88-Inch Cyclotron at Lawrence Berkeley National Laboratory. The (p,df) reaction channels on 236U and 238U targets were used as a surrogate to determine the σ[236U(n,f)]/σ[234U(n,f)] cross-section ratio. The (p,tf) reaction channels were also measured with the same targets as a surrogate for the σ[235U(n,f)]/σ[(233U(n,f)] ratio. For the (p,df) and (p,tf) surrogate measurements, there is good agreement with accepted (n,f) values over equivalent neutron energy ranges of En=0–7 MeV and En=0–5.5 MeV, respectively. An internal surrogate ratio method comparing the (p,d) and (p,t) reaction channels on a single target is also discussed. The σ[234U(n,f)]/σ[233U(n,f)] and σ[236U(n,f)]/σ[235U(n,f)] cross-section ratios are extracted using this method for the 236U and 238U targets, respectively. The resulting fission cross-section ratios show relatively good agreement with accepted values up to En∼5 MeV